A research study for people with covid-19 sars-cov-2 infection, evaluating an investigational approach.
This research study is evaluating an investigational approach for people with covid-19 sars-cov-2 infection. Eligibility is reviewed by the study team if you apply. Contact the clinic to learn more.
A member of the study team at Invictus Clinical Research Group will reach out to talk with you about the study, answer your questions and go over whether it may be a fit for you. Contacting the clinic does not sign you up for anything.
Yes. Taking part in a research study is always your choice. You can ask questions at any time, and you can decide not to join, or to stop later, without it affecting your regular medical care.
Clinical research studies are reviewed by an Institutional Review Board (IRB), an independent committee that protects the rights, safety and well-being of the people who take part. The study team follows the study plan the IRB reviewed.
Taking part usually includes visits with the study team at the clinic. Before you decide, the team will explain the visit schedule, what happens at each visit and any study-related care, and will answer your questions.
The information you share is sent only to Invictus Clinical Research Group and is used to contact you about this study. The study team will explain how your information is protected before you decide whether to take part.
Have a question for us?
Send us a message here and we will be with you shortly.
Our hours of operations are Monday to Friday – 8:00 AM to 5:00 PM.
